Melanoma miRNA trafficking controls tumour primary niche formation

Nature Cell Biology

Volumn 18, Issue 9, 2016, Pages 1006-1017

  Dror, Shani ^a   Sander, Laureen ^b   Schwartz, Hila ^a   Sheinboim, Danna ^a   Barzilai, Aviv ^c   Dishon, Yuval ^a   Apcher, Sebastien ^d   Golan, Tamar ^a   Greenberger, Shoshana ^c   Barshack, Iris ^c   Malcov, Hagar ^a   Zilberberg, Alona ^a   Levin, Lotan ^a   Nessling, Michelle ^b   Friedmann, Yael ^e   Igras, Vivien ^f   Barzilay, Ohad ^a   Vaknine, Hananya ^g   Brenner, Ronen ^g   Zinger, Assaf ^h   Schroeder, Avi ^h   Gonen, Pinchas ^a   Khaled, Mehdi ⁱ   Erez, Neta ^a   Hoheisel, Jörg D ^b   Levy, Carmit ^a   more..

^a TEL AVIV UNIVERSITY   (Israel)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c SHEBA MEDICAL CENTER   (Israel)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^f MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^g WOLFSON MEDICAL CENTER   (Israel)

^h TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

ⁱ INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 211; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG; MIRN211 MICRORNA, HUMAN; MIRN211 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; MELANOMA; MELANOMA CELL; MELANOSOME; MICROARRAY ANALYSIS; MICRORNA TRAFFICKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PURIFICATION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; ANIMAL; CELL MOTION; EPIDERMIS; FIBROBLAST; GENETICS; MELANOCYTE; METABOLISM; PATHOLOGY; SKIN TUMOR; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL CULTURE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; EPIDERMIS; FIBROBLASTS; HUMANS; MELANOCYTES; MELANOMA; MELANOSOMES; MICE; MICRORNAS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84983372037     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3399     Document Type: Article

References (67)

1. Bell, R. E., & Levy, C. The three M?s: melanoma, microphthalmia-Associated transcription factor and microRNA. Pigment Cell Melanoma Res. 24, 1088-1106 (2011
2. Raposo, G., & Marks, M. S. Melanosomes-dark organelles enlighten endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 8, 786-797 (2007
3. Watabe, H., Kushimoto, T., Valencia, J. C., & Hearing, V. J. in Current Protocols in Cell Biology (eds Bonifacino, J. S., et al.) Ch. 3, Unit 3, 14 (2005
4. Joshi, P. G. Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res. 20, 380-384 (2007
5. Yamaguchi, Y., & Hearing, V. J. Physiological factors that regulate skin pigmentation. Biofactors 35, 193-199 (2009
6. Basrur, V., et al. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J. Proteome Res. 2, 69-79 (2003
7. Boissy, R. E. Melanosome transfer to and translocation in the keratinocyte. Exp. Dermatol. 12, 5-12 (2003
8. Lazova, R., & Pawelek, J. M. Why do melanomas get so dark? Exp. Dermatol. 18, 934-938 (2009
9. Chen, K. G., et al. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc. Natl Acad. Sci. USA 103, 9903-9907 (2006
10. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004
11. Lu, J., et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005
12. Levy, C., et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol. Cell 40, 841-849 (2010
13. Asangani, I., et al. MicroRNA-21 (miR-21) post-Transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (2008
14. Levy, C., et al. Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell 141, 994-1005 (2010
15. Bedrosian, I., et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (or D1 mm) with vertical growth phase Ann. Surg. Oncol 7 262-267 2000
16. Sorrell, J. M., & Caplan, A. I. Fibroblast heterogeneity: more than skin deep. J. Cell Sci. 117, 667-675 (2004
17. Bhowmick, N. A., Neilson, E. G., & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337 (2004
18. Kalluri, R., & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006
19. Servais, C., & Erez, N. From sentinel cells to inflammatory culprits: cancer-Associated fibroblasts in tumour-related inflammation. J. Pathol. 229, 198-207 (2013
20. Orimo, A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005
21. Tlsty, T. D., & Hein, P. W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11, 54-59 (2001
22. Cornil, I., et al. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl Acad. Sci. USA 88, 6028-6032 (1991
23. Erez, N., Truitt, M., Olson, P., Arron, S. T., & Hanahan, D. Cancer-Associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappa;B-dependent manner. Cancer Cell 17, 135-147 (2010
24. Quante, M., et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19, 257-272 (2011
25. Sharon, Y., et al. Tumor-derived osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer. Cancer Res. 75, 963-973 (2015
26. Serini, G., & Gabbiani, G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250, 273-283 (1999
27. Flach, E. H., Rebecca, V. W., Herlyn, M., Smalley, K. S., & Anderson, A. R. Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol. Pharm. 8, 2039-2049 (2011
28. Gallagher, P. G., et al. Gene expression profiling reveals cross-Talk between melanoma and fibroblasts: implications for host-Tumor interactions in metastasis. Cancer Res. 65, 4134-4146 (2005
29. Öhlund, D., Elyada, E., & Tuveson, D. Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211, 1503-1523 (2014
30. Mitra, A. K., et al. MicroRNAs reprogram normal fibroblasts into cancer-Associated fibroblasts in ovarian cancer. Cancer Discov. 2, 1100-1108 (2012
31. Ruiter, D., Bogenrieder, T., Elder, D., & Herlyn, M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 3, 35-43 (2002
32. Haass, N. K., Smalley, K. S., Li, L., & Herlyn, M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 18, 150-159 (2005
33. Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 5, 1640-1646 (2006
34. Hoashi, T., et al. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J. 24, 1616-1629 (2010
35. Torisu, H., et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFα and IL-1. Int. J. Cancer 85, 182-188 (2000
36. Mathivanan, S., & Simpson, R. J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000 (2009
37. Sato, I., Miyado, M., & Sunohara, M. NADH dehydrogenase activity and expression of mRNA of complex I (ND1, 51kDa, and 75kDa) in heart mitochondria of klotho mouse. Okajimas Folia Anat. Jpn. 82, 49-56 (2005
38. Barker, H. E., Bird, D., Lang, G., & Erler, J. T. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling. Mol. Cancer Res. 11, 1425-1436 (2013
39. Bellei, B., Pitisci, A., Migliano, E., Cardinali, G., & Picardo, M. Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-Associated Kinase, a regulator of cathepsins maturation. Cell. Signal. 26, 716-723 (2014
40. Peinado, H., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012
41. Xiao, D., et al. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS ONE 7, e46874 (2012
42. Lu, Y. J., et al. A molecular fluorescent dye for specific staining and imaging of RNA in live cells: a novel ligand integration from classical thiazole orange and styryl compounds. Chem. Commun. (Camb) 51, 15241-15244 (2015
43. Sun, V., Zhou, W., Majid, S., Kashani-Sabet, M., & Dar, A. MicroRNA-mediated regulation of melanoma. Br. J. Dermatol. 171, 234-241 (2014
44. Leibowitz-Amit, R., Sidi, Y., & Avni, D. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma. Pigment Cell Melanoma Res. 25, 740-757 (2012
45. Zhao, F., et al. Activation of p38 mitogen-Activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma. Clin. Cancer Res. 15, 4382-4390 (2009
46. Hankins, G. R., et al. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12, 2003-2009 (1996
47. Oates, A. J., et al. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res. Treat. 47, 269-281 (1998
48. Chappell, S., Walsh, T., Walker, R., & Shaw, J. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br. J. Cancer 76, 1558 (1997
49. Gemma, A., et al. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factorα 1 (TGF-α 1). Lung Cancer 30, 91-98 (2000
50. Aprelikova, O., et al. The role of miR-31 and its target gene SATB2 in cancerassociated fibroblasts. Cell Cycle 9, 4387-4398 (2010
51. Golan, T., et al. Interactions of melanoma cells with distal keratinocytes trigger metastasis via notch signaling inhibition of MITF. Mol. Cell (2015
52. Bell, R. E., et al. Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1. J. Invest. Dermatol. 134, 441-451 (2014
53. Soderberg, A., Barral, A. M., Soderstrom, M., Sander, B., & Rosen, A. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic. Biol. Med. 43, 90-99 (2007
54. Gu, J., et al. Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-Associated fibroblasts through TGF-β/Smad pathway. PLoS ONE 7, e52465 (2012
55. van den Boorn, J. G., et al. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J. Invest. Dermatol. 131, 1240-1251 (2011
56. Pinner, S., et al. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 69, 7969-7977 (2009
57. Lazar, I., et al. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell Melanoma Res. 28, 464-475 (2015
58. D'Souza-Schorey, C., & Clancy, J. W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 26, 1287-1299 (2012
59. Morris, J. K. A formaldehyde glutaraldehyde fixative of high osmolality for use in electron microscopy. J. Cell Biol. 27, 137-139 (1965
60. Ros, J. R., Rodriguez-Lopez, J. N., & Garcia-Canovas, F. Effect of L-Ascorbic acid on the monophenolase activity of tyrosinase. Biochem. J. 295, 309-312 (1993
61. Ritchie, M. E., Dunning, M. J., Smith, M. L., Shi, W., & Lynch, A. G. BeadArray expression analysis using bioconductor. PLoS Comput. Biol. 7, e1002276 (2011
62. Kallio, M. A., et al. Chipster: user-friendly analysis software for microarray and other high-Throughput data. BMC Genomics 12, 507 (2011
63. Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523-530 (2014
64. Alhamdani, M. S., et al. Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. J. Proteome Res. 9, 963-971 (2010
65. Bogatkevich, G. S., Tourkina, E., Silver, R. M., & Ludwicka-Bradley, A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J. Biol. Chem. 276, 45184-45192 (2001
66. Magina, S., et al. Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect. Arch. Dermatol. Res. 303, 201-210 (2011
67. Pons, M., Foradada, M., & Estelrich, J. Liposomes obtained by the ethanol injection method. Int. J. Pharm. 95, 51-56 (1993